Infinite Load Articles

Details emerge of first Huntington’s disease gene therapy clinical trial

UniQure announces key details of its planned trial to assess the safety and ability of AMT-130 gene therapy to lower the problematic huntingtin protein...

EIP Pharma Initiates New Study with Neflamapimod for the Treatment of...

EIP Pharma, Inc., a CNS-focused therapeutics company, today announced the initiation of a new Phase 2 proof-of-concept study evaluating neflamapimod as a treatment for...

Sangamo Therapeutics Announces Nature Medicine Publication Detailing the Activity of Disease...

Jul. 1, 2019-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced the publication of a manuscript describing the activity of allele-selective zinc finger...

Distinct clinical profiles of Huntington’s disease can be associated with two...

Cognitive-motor and psychiatric profiles of Huntington's disease show a different pattern of brain alterations The identification of specific neural signatures can help develop specific biomarkers...

BGU Scientists Duplicate Blood-Brain Barrier Outside the Body

​Scientists can't make a living copy of your brain outside your body. That's the stuff of science fiction. But in a new study, they...

A new molecular mechanism could explain the origins of the depressive...

About 40 % of the affected patients with Huntington’s disease –a neurodegenerative pathology- show depression symptoms, even in early stages before the apparition of...

LATEST ARTICLES

0 Condivisioni